The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of KIT expression with higher FLT3 mutations and impact on clinical outcome in patients newly diagnosed with acute myeloid leukemia (AML).
Hassan Alkhateeb
No relevant relationships to disclose
Mark Robert Litzow
No relevant relationships to disclose
Firas Baidoun
No relevant relationships to disclose
Shahrukh Hashmi
No relevant relationships to disclose
William J. Hogan
No relevant relationships to disclose
Mrinal M. Patnaik
No relevant relationships to disclose
Michelle A. Elliott
No relevant relationships to disclose
Dong Chen
No relevant relationships to disclose
Aref Al-Kali
No relevant relationships to disclose